# PJT Partners Inc.: financial statements, quarterly

PJT · NYSE · CIK 1626115 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pjt.md) · [Financials](/companies/pjt/financials.md) · [Filings](/companies/pjt/filings.md) · [Insiders](/companies/pjt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pjt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [275](/filings/0000950170-24-119582.md) | [324 d](/filings/0001193125-26-076969.md) | [327](/filings/0000950170-25-061984.md) | [358](/filings/0000950170-25-100937.md) | [320](/filings/0001193125-25-269723.md) | [471 d](/filings/0001193125-26-076969.md) | [322](/filings/0001193125-26-197485.md) | [401](/filings/0001193125-26-326245.md) | [442](/filings/0001193125-25-269723.md) | [531 d](/filings/0001193125-26-076969.md) | [411](/filings/0001193125-26-197485.md) | [483](/filings/0001193125-26-326245.md) |
| Income tax | $m | [11.4](/filings/0000950170-24-119582.md) | [6.2 d](/filings/0001193125-26-076969.md) | [0.5](/filings/0000950170-25-061984.md) | [11.4](/filings/0000950170-25-100937.md) | [8.3](/filings/0001193125-25-269723.md) | [11.9 d](/filings/0001193125-26-076969.md) | [(21.6)](/filings/0001193125-26-197485.md) | [15.0](/filings/0001193125-26-326245.md) | [16.0](/filings/0001193125-25-269723.md) | [23.7 d](/filings/0001193125-26-076969.md) | [(8.9)](/filings/0001193125-26-197485.md) | [20.8](/filings/0001193125-26-326245.md) |
| Net income | $m | [17.4](/filings/0000950170-24-119582.md) | [24.9 d](/filings/0001193125-26-076969.md) | [32.6](/filings/0000950170-25-061984.md) | [28.3](/filings/0000950170-25-100937.md) | [22.2](/filings/0001193125-25-269723.md) | [51.3 d](/filings/0001193125-26-076969.md) | [54.0](/filings/0001193125-26-197485.md) | [32.9](/filings/0001193125-26-326245.md) | [39.8](/filings/0001193125-25-269723.md) | [53.4 d](/filings/0001193125-26-076969.md) | [60.5](/filings/0001193125-26-197485.md) | [45.8](/filings/0001193125-26-326245.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [116](/filings/0000950170-23-058860.md) | [356](/filings/0000950170-25-029132.md) | [216](/filings/0000950170-24-052960.md) | [164](/filings/0000950170-24-090024.md) | [149](/filings/0000950170-24-119582.md) | [484](/filings/0001193125-26-076969.md) | [194](/filings/0000950170-25-061984.md) | [215](/filings/0000950170-25-100937.md) | [400](/filings/0001193125-25-269723.md) | [539](/filings/0001193125-26-326245.md) | [309](/filings/0001193125-26-197485.md) | [236](/filings/0001193125-26-326245.md) |
| Total assets | $m | [1,195](/filings/0000950170-23-058860.md) | [1,435](/filings/0000950170-25-029132.md) | [1,302](/filings/0000950170-24-052960.md) | [1,418](/filings/0000950170-24-090024.md) | [1,560](/filings/0000950170-24-119582.md) | [1,635](/filings/0001193125-26-076969.md) | [1,397](/filings/0000950170-25-061984.md) | [1,511](/filings/0000950170-25-100937.md) | [1,719](/filings/0001193125-25-269723.md) | [1,843](/filings/0001193125-26-326245.md) | [1,564](/filings/0001193125-26-197485.md) | [1,756](/filings/0001193125-26-326245.md) |
| Total liabilities | $m | [383](/filings/0000950170-23-058860.md) | [574](/filings/0000950170-25-029132.md) | [474](/filings/0000950170-24-052960.md) | [570](/filings/0000950170-24-090024.md) | [679](/filings/0000950170-24-119582.md) | [734](/filings/0001193125-26-076969.md) | [572](/filings/0000950170-25-061984.md) | [663](/filings/0000950170-25-100937.md) | [789](/filings/0001193125-25-269723.md) | [834](/filings/0001193125-26-326245.md) | [634](/filings/0001193125-26-197485.md) | [773](/filings/0001193125-26-326245.md) |
| Shareholders' equity | $m | [193](/filings/0000950170-23-058860.md) | [245](/filings/0000950170-25-029132.md) | [175](/filings/0000950170-24-052960.md) | [134](/filings/0000950170-24-090024.md) | [159](/filings/0000950170-24-119582.md) | [187](/filings/0001193125-26-076969.md) | [149](/filings/0000950170-25-061984.md) | [167](/filings/0000950170-25-100937.md) | [229](/filings/0001193125-25-269723.md) | [308](/filings/0001193125-26-326245.md) | [273](/filings/0001193125-26-197485.md) | [312](/filings/0001193125-26-326245.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [150 d](/filings/0000950170-24-119582.md) | [124 d](/filings/0001193125-26-076969.md) | [(38.8)](/filings/0000950170-25-061984.md) | [194 d](/filings/0000950170-25-100937.md) | [180 d](/filings/0001193125-25-269723.md) | [196 d](/filings/0001193125-26-076969.md) | [(75.9)](/filings/0001193125-26-197485.md) | [190 d](/filings/0001193125-26-326245.md) | [256 d](/filings/0001193125-25-269723.md) | [156 d](/filings/0001193125-26-076969.md) | [64.3](/filings/0001193125-26-197485.md) | [237 d](/filings/0001193125-26-326245.md) |
| Capital expenditure | $m | [0.5 d](/filings/0000950170-24-119582.md) | [0.5 d](/filings/0001193125-26-076969.md) | [0.4](/filings/0000950170-25-061984.md) | [0.5 d](/filings/0000950170-25-100937.md) | [1.9 d](/filings/0001193125-25-269723.md) | [0.4 d](/filings/0001193125-26-076969.md) | [2.0](/filings/0001193125-26-197485.md) | [11.5 d](/filings/0001193125-26-326245.md) | [15.2 d](/filings/0001193125-25-269723.md) | [17.2 d](/filings/0001193125-26-076969.md) | [8.3](/filings/0001193125-26-197485.md) | [10.6 d](/filings/0001193125-26-326245.md) |
| Dividends paid | $m | [6.1 d](/filings/0000950170-24-119582.md) | [6.1 d](/filings/0001193125-26-076969.md) | [6.2](/filings/0000950170-25-061984.md) | [6.0 d](/filings/0000950170-25-100937.md) | [6.0 d](/filings/0001193125-25-269723.md) | [6.0 d](/filings/0001193125-26-076969.md) | [6.3](/filings/0001193125-26-197485.md) | [6.1 d](/filings/0001193125-26-326245.md) | [6.1 d](/filings/0001193125-25-269723.md) | [6.1 d](/filings/0001193125-26-076969.md) | [6.5](/filings/0001193125-26-197485.md) | [6.4 d](/filings/0001193125-26-326245.md) |
| Share repurchases | $m | [1.9 d](/filings/0000950170-24-119582.md) | [10.8 d](/filings/0001193125-26-076969.md) | [106](/filings/0000950170-25-061984.md) | [56.1 d](/filings/0000950170-25-100937.md) | [23.0 d](/filings/0001193125-25-269723.md) | [49.5 d](/filings/0001193125-26-076969.md) | [127](/filings/0001193125-26-197485.md) | [63.4 d](/filings/0001193125-26-326245.md) | [0.0 d](/filings/0001193125-25-269723.md) | [4.7 d](/filings/0001193125-26-076969.md) | [61.3](/filings/0001193125-26-197485.md) | [53.2 d](/filings/0001193125-26-326245.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 24,800,541 at 2023-04-24, from the cover of the [10-Q filed 2023-05-03](/filings/0000950170-23-017242.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.